Navigation Links
NHP Reports 2009 First Quarter Results
Date:5/7/2009

are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share.

FIRST QUARTER 2009 INVESTMENT ACTIVITY

We sold three buildings in the first quarter for approximately $35.0 million in gross proceeds. We also invested $8.0 million in revenue producing capital expenditures at a blended yield of 8.3% on our existing triple net portfolio.

In February 2009, we entered into an agreement with Brookdale Senior Living, Inc. whereby we became a lender with an original commitment of $8.8 million under their $230.0 million revolving loan facility with a maturity date of August 31, 2010. We originally funded $7.4 million, and at March 31, 2009, $5.9 million remained outstanding.

Pacific Medical Buildings LLC ("PMB") Update - In the first quarter of 2009, we terminated our obligation with respect to the following five buildings: Orange, CA; Poway, CA; Mission Viejo, CA; Honolulu, HI; and Reno, NV.

FIRST QUARTER 2009 FINANCING TRANSACTIONS

In the first quarter of 2009, we paid off $27.0 million of senior notes that came due with a weighted average interest rate of 7.61%. We also extended a $32.9 million secured note to April 2010 and placed $6.6 million of additional secured debt.

On April 1, 2009, we retired $30.0 million of senior notes with an interest rate o
'/>"/>

SOURCE Nationwide Health Properties, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
2. PLC Systems Reports First Quarter 2009 Results
3. Perrigo Reports Record Third Quarter
4. Symmetry Medical Reports First Quarter 2009 Financial Results
5. Orchid Cellmark Reports Improved First Quarter 2009 Financial Results
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Isis Reports Strong Financial Results and Highlights for First Quarter of 2009
8. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
9. Stereotaxis Reports First Quarter 2009 Financial Results
10. Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
11. The Ensign Group Reports First Quarter 2009 Earnings of $0.38 per Share; Reaffirms 2009 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... Richard Plemper, a professor in the new Institute ... received a five-year, $2.83 million federal grant to ... infection. , The grant from the Eunice Kennedy ... Development of the National Institutes of Health will ... anti-RSV drug and at least one distinct alternative ...
(Date:4/24/2014)... Ill. It is better to give than to receive ... giving, a new study suggests. , The study found that ... as giving their money to family members, are less likely ... from taking risks or keeping the money for themselves. , ... the National Academy of Sciences . , The study focused ...
(Date:4/24/2014)... 2009 the influenza pH1N1 virus caused the first flu ... in May 2009 and killed more than 50 people ... Finns mainly during flu epidemics (winter/spring seasons). , ... serious complicated illnesses. World Health Organization has recommended Tamiflu ... The disadvantage of this drug is that it targets ...
(Date:4/23/2014)... for a new experimental drug to treat acute ... with CPX-351, a combination of the chemotherapeutic drugs ... patients treated with the standard drug formulation. ... aggressive blood cancer with very low rates of ... Lancet, M.D., senior member of the Department of ...
(Date:4/23/2014)... exposed to high-energy particles, simulating conditions astronauts would face ... attention and slower reaction times, even when the radiation ... cognitive impairments which affected a large subset, but ... be linked to protein changes in the brain, the ... in humans, suggest it may be possible to develop ...
Breaking Medicine News(10 mins):Health News:Study: Altruistic adolescents less likely to become depressed 2Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3
... don,t delay surgery, research shows , FRIDAY, June 4 ... a suddenly inflamed gallbladder improves survival and reduces costs ... Dr. Taylor S. Riall, associate professor of surgery at ... colleagues analyzed data on 29,818 Medicare beneficiaries hospitalized for ...
... and heart rate, but decreases stress hormone levels, researchers find ... gets angry it is often possible to see them physically ... is going on inside the body. , The new study ... when they are angry, right down to the cellular level. ...
... ... Resources, Inc. (GDAR) CFO Graham Larmer. , ... Hollywood, FL (PRWEB) June 4, 2010 -- Golden Age Resources, Inc., (pink sheets; ... Geometrix Engineering, Inc. of Hollywood, FL to finalize the development of Cobra. This is a ...
... ... desktop virtualisation software SoftXpand, as the exclusive distributor for supplying its award-winning multi-user solution ... ... has been appointed by Miniframe, supplier of innovative desktop virtualisation software SoftXpand, as the ...
... Patent ... ... Inc. (Chrono), a privately held company that pioneers chrono therapeutic health care products, announced ... systems and applications. , , ,Guy DiPierro, CEO of Chrono, noted that this new ...
... ... the tablets and capsules they often struggle to take. Publix is launching Pill Glide in all ... both strawberry and grape flavors. , ... MD (PRWEB) June 4, 2010 -- FLAVORx Inc . announced today the launch of its ...
Cached Medicine News:Health News:Removing Gallbladder Sooner Cuts Costs, Readmissions 2Health News:Anger Spurs Surprising Changes in the Body 2Health News:Gulf Oil Spill Goes from Disaster to Catastrophe 2Health News:London Web Expands Green IT with SoftXpand Desktop Virtualisation Solution 2Health News:London Web Expands Green IT with SoftXpand Desktop Virtualisation Solution 3Health News:US Patent Granted To Chrono Therapeutics Inc. For Its Chrono-Pharmacological Drug Delivery Systems And Applications 2Health News:Publix Pharmacy Now Offers Pill Glide, an Innovative New Way for Children and Adults to Take Vitamins, Supplements and Medications 2Health News:Publix Pharmacy Now Offers Pill Glide, an Innovative New Way for Children and Adults to Take Vitamins, Supplements and Medications 3
(Date:1/14/2014)... FRAMINGHAM, Mass. , Jan. 14, 2014 ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that it expects revenues for the ... bringing expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), ... that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... The terms of the acquisition were not disclosed. ... company providing a wide range of sleep, mobility, and respiratory ...
(Date:1/14/2014)... 14, 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... April 27 AstraZeneca LP and AstraZeneca ... resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug ... by the Food and Drug Administration (FDA), the Departments ... Fraud Enforcement Action Team (HEAT) announced today.  Such unapproved ...
... April 27 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" ... traditional Chinese medicines ("TCM"), today announced,the appointment of Mr. Dianjun ... , and that the Company has established nominating and compensation,committees. , ... ...
Cached Medicine Technology:Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing 2Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing 3Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing 4Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing 5Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing 6Renhuang Appoints New Director and Establishes Nominating and Compensation Committee 2Renhuang Appoints New Director and Establishes Nominating and Compensation Committee 3
... Diagnostics iQ®200 Automated Urine Microscopy Analyzer ... Recognition (APR®) software to classify urine ... report results. The iQ200 eliminates most ... interpret particle images by automating specimen ...
... The ISOPLATER® is an automatic ... load, streak and stack up to ... hour. Automated streaking results in substantial ... productivity, improves isolation rates, standardizes streaking ...
... a brand-new high technology state-of-the-art system offering ... and ease-of-use for every user. The flexible ... basic investigations as well as research purposes. ... This allows you to obtain the functionality ...
... Delphis™ is ideal for any clinical ... to performing a UDS procedure. Customize ... the options of a Pocket PC, ... Delphis with Bluetooth™ wireless technology allows ...
Medicine Products: